Chronic Limb-Threatening Ischemia: all 357 studies

Page 4 of 4. Open to participants first (72), then studies with results posted, then the rest; newest registration first within each.

• Study of the Clinical Efficacy of Autologous SCT in Patients With Critical Limb IschemiaStatus unknownNCT01311011
• Feasibility of Peripheral Angioplasty in Type D TASCII LesionsCompletedNCT01297387
• Scandinavian Miller Collar StudyCompletedNCT01285986Not applicable
• Swedish External Support StudyCompletedNCT01273740Not applicable
• Diabetic Foot and Vascular Progenitor CellsStatus unknownNCT01269580
• Human Adipose Derived Mesenchymal Stem Cells for Critical Limb Ischemia (CLI) in Diabetic PatientsCompletedNCT01257776Phase 1/2
• Bone Marrow Aspirate Concentrate (BMAC) for Treatment of Critical Limb Ischemia (CLI)CompletedNCT01245335Phase 3
• Autologous Bone Marrow Stem Cell Transfer in Patients With Chronical Critical Limb Ischemia and Diabetic FootCompletedNCT01232673Phase 2
• Umbilical Cord Mesenchymal Stem Cells Injection for Diabetic FootStatus unknownNCT01216865Phase 1/2
• Distal Venous Arterialisation of Ischemic LimbStatus unknownNCT01211925Phase 2/3
• Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part II) (DCLI-II)Status unknownNCT01173094Phase 4
• Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part I)Status unknownNCT01171703Phase 4
• Comparison of Stent and Prothesis Bypass in Superficial Femoral ArteryStatus unknownNCT01147419Phase 4
• Aspirin Resistance and Prognosis of Patients With Critical Limb IschaemiaCompletedNCT01104441
• Induced Wound Healing by Application of Expanded Bone Marrow Stem Cells in Diabetic Patients With Critical Limb IschemiaCompletedNCT01065337Phase 2
• Efficacy and Safety of Umbilical Cord Blood Injection for Critical Limb IschemiaTerminatedNCT01019681Phase 1
• Intraarterial Infusion of Autologous Bone Marrow in Diabetic Patients With Chronic Ischemia of Lower Limbs (CLI) no RevascularizationCompletedNCT00987363Phase 1/2
• Safety Study of MultiGeneAngio in Patients With Chronic Critical Limb IschemiaActive, not recruitingNCT00956332Phase 1/2
• Safety of Intramuscular Injections (IM) of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia (CLI)CompletedNCT00951210Phase 1
• A Clinical Trial on Diabetic Foot Using Peripheral Blood Derived Stem Cells for Treating Critical Limb IschemiaStatus unknownNCT00922389Phase 1/2
• Safety of Intramuscular Injection of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb IschemiaCompletedNCT00919958Phase 1
• Safety Study of Adult Stem Cells to Treat Patients With Severe Leg Artery DiseaseTerminatedNCT00913900Phase 1
• Mesenchymal Stem Cells in Critical Limb IschemiaCompletedNCT00883870Phase 1/2
• Validation of OxyVu for Assessing Level of Amputation With Comparison to Other ModalitiesStatus unknownNCT00767923
• Efficacy Study of Iliac Stents to Treat TASC A-B-C-D Iliac Artery LesionsCompletedNCT00764777Phase 4
• A Retrospective Analysis of Patients With Full Thickness Wounds in Limbs With Critical IschemiaCompletedNCT00760357
• Phase II Combination Stem Cell Therapy for the Treatment of Severe Leg IschemiaCompletedNCT00721006Phase 2
• Safety Study of UT-15C SR (Oral Treprostinil) in Patients Undergoing a Lower Limb Endovascular ProcedureCompletedNCT00651885Phase 2
• DURABILITY-200: EverFlex 200mm Long Nitinol Stents in TASC C&D Femoropopliteal LesionsCompletedNCT00637741Phase 4
• Injection of Autologous CD34-Positive Cells for Critical Limb IschemiaCompletedNCT00616980Phase 1/2
• Feasability Study of Autologous Bone Marrow Aspirate Concentrate for Treatment of CLICompletedNCT00595257Phase 1/2
• Efficacy and Safety of XRP0038/NV1FGF in Critical Limb Ischemia Patients With Skin LesionsCompletedNCT00566657Phase 3
• Autologous Bone Marrow-derived Mononuclear Cells for Therapeutic Arteriogenesis in Patients With Limb IschemiaStatus unknownNCT00539266Phase 2/3
• ACPs in Severe PAD/CLI by Direct Intramuscular InjectionCompletedNCT00523731Phase 1
• Combination Stem Cell Therapy for the Treatment of Severe Leg IschemiaCompletedNCT00518401Phase 1
• A Non-Randomized Study of the NightHawk Peripheral Plaque Excision System During Plaque Excision of Peripheral Arterial DiseaseTerminatedNCT00516308Phase 2
• Study to Evaluate the Safety & Performance of the Xpert(TM) Stent in Treating Below-the-knee Lesions in Patients Undergoing Percutaneous Intervention for Chronic CLI.CompletedNCT00515346Phase 1
• Drug Eluting Stents In The Critically Ischemic Lower LegCompletedNCT00510393Phase 2
• Plaque Removal Versus Open Bypass Surgery For Critical Limb IschemiaTerminatedNCT00504088Phase 4
• Stem Cells for Treating Critical IschemiaStatus unknownNCT00488020Phase 1
• PTA and Drug Eluting Stents for Infrapopliteal Lesions in Critical Limb IschemiaStatus unknownNCT00471289Phase 2/3
• Use of Ixmyelocel-T (Formerly Vascular Repair Cells [VRC]) in Patients With Peripheral Arterial Disease to Treat Critical Limb IschemiaCompletedNCT00468000Phase 2
• Cryoplasty CLIMB-registryCompletedNCT00459888Phase 4
• UT-15C SR in the Treatment of Critical Limb IschemiaStatus unknownNCT00445159Phase 2
• Effect of Hemodialysis on Toe Pressure- and Finger Pressure and Skin Autofluorescence in Hemodialysis PatientsCompletedNCT00431314
• Randomized Study of Pregabalin for Pain Reduction in Patients With Rest Pain and Lower Limb IschemiaTerminatedNCT00403780Phase 4
• ALD-301 for Critical Limb Ischemia, Randomized TrialCompletedNCT00392509Phase 1/2
• Intra-arterial Stem Cell Therapy for Patients With Chronic Limb Ischemia (CLI)CompletedNCT00371371Phase 1/2
• VEGF Gene Transfer for Critical Limb IschemiaCompletedNCT00304837Phase 1
• Choice of Material for Above-Knee Femoro-Popliteal Bypass Prosthetic Graft (PopUp)CompletedNCT00300690Phase 4
• Safety/Feasibility Study of HBOC-201 in Amputation at/Below Knee From Critical Lower Limb IschemiaTerminatedNCT00300040Phase 2
• Safety and Feasibility Study of Autologous Bone Marrow Cell Transplantation in Patients With Peripheral Arterial Occlusive Disease (PAOD)CompletedNCT00282646Phase 2
• Measurement of Tissue Oxygen Saturation in Chronic Critical Limb IschemiaTerminatedNCT00224328
• TACT-NAGOYA: Therapeutic Angiogenesis Using Cell TransplantationStatus unknownNCT00145262
• Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass GraftTerminatedNCT00067041Phase 2/3
• Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization ProceduresTerminatedNCT00060996Phase 3
• Study of HGF Via Plasmid Vector to Improve Perfusion in Critical Limb IschemiaCompletedNCT00060892Phase 2

← Chronic Limb-Threatening Ischemia overview